Loading...
Hua Medicine (Shanghai) Ltd.
HUMDF•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$0.41
$0.00(0.00%)
Hua Medicine (Shanghai) Ltd. (HUMDF) Financial Performance & Income Statement Overview
Review Hua Medicine (Shanghai) Ltd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
234.02%
↑ 234.02%
Operating Income Growth
-21.98%
↓ 21.98%
Net Income Growth
-18.42%
↓ 18.42%
Operating Cash Flow Growth
-147.00%
↓ 147.00%
Operating Margin
-280.07%
↓ 280.07%
Gross Margin
41.99%
↑ 41.99%
Net Profit Margin
-191.69%
↓ 191.69%
ROE
805.94%
↑ 805.94%
ROIC
-24.75%
↓ 24.75%
Hua Medicine (Shanghai) Ltd. (HUMDF) Income Statement & Financial Overview
Review Hua Medicine (Shanghai) Ltd.'s (HUMDF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $76.61M | $76.61M | $51.33M | $51.33M |
| Cost of Revenue | $38.13M | $38.13M | $27.45M | $27.45M |
| Gross Profit | $38.48M | $38.48M | $23.88M | $23.88M |
| Gross Profit Ratio | $0.50 | $0.50 | $0.47 | $0.47 |
| R&D Expenses | $47.66M | $47.66M | $59.89M | $59.89M |
| SG&A Expenses | $73.86M | $73.86M | $61.11M | $61.11M |
| Operating Expenses | $121.52M | $121.52M | $121.00M | $121.00M |
| Total Costs & Expenses | $159.65M | $159.65M | $148.45M | $148.45M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $3.71M | $3.71M | $3.77M | $3.77M |
| EBITDA | -$79.33M | -$79.33M | -$93.35M | -$93.35M |
| EBITDA Ratio | -$1.04 | -$1.04 | -$1.82 | -$1.82 |
| Operating Income | -$83.04M | -$83.04M | -$97.12M | -$97.12M |
| Operating Income Ratio | -$1.08 | -$1.08 | -$1.89 | -$1.89 |
| Other Income/Expenses (Net) | $29.09M | $29.09M | $26.00M | $26.00M |
| Income Before Tax | -$53.95M | -$53.95M | -$71.12M | -$71.12M |
| Income Before Tax Ratio | -$0.70 | -$0.70 | -$1.39 | -$1.39 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$53.95M | -$53.95M | -$71.12M | -$71.12M |
| Net Income Ratio | -$0.70 | -$0.70 | -$1.39 | -$1.39 |
| EPS | -$0.05 | -$0.05 | -$0.07 | -$0.07 |
| Diluted EPS | -$0.05 | -$0.05 | -$0.07 | -$0.07 |
| Weighted Avg Shares Outstanding | $982.15M | $982.15M | $980.65M | $980.65M |
| Weighted Avg Shares Outstanding (Diluted) | $982.14M | $982.14M | $980.65M | $980.65M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan